The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. Knoche SM, Brumfield GL, Goetz BT, Sliker BH, et al. PLoS One 2022;17:e0273518.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Knoche SM, Brumfield GL, Goetz BT, Sliker BH, et al. The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. PLoS One 2022;17:e0273518.
PMID: 36126055